Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
REGENERX BIOPHARMACEUTICALS INC (RGRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/07/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events Interactive Data |
| 07/11/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 07/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 07/06/2023 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 36.1% stake in RegeneRx Biopharmaceuticals, Inc. |
| 07/06/2023 |
4
| Essetifin SPA (10% Owner) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Bought options to buy
@ $50000, valued at
$0
Acquired 3,750,000 warrants
@ $0 |
|
| 04/03/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/19/2022 |
4
| GOLDSTEIN ALLAN L (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 480,000 options to buy
@ $0.19, valued at
$91.2k
|
|
| 05/19/2022 |
4
| Bove Mauro (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 240,000 options to buy
@ $0.19, valued at
$45.6k
|
|
| 05/19/2022 |
4
| Noseda Alessandro (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 240,000 options to buy
@ $0.19, valued at
$45.6k
|
|
| 05/19/2022 |
4
| Elsey R Don (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 290,000 options to buy
@ $0.19, valued at
$55.1k
|
|
| 05/19/2022 |
4
| MCNAY JOSEPH C (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 290,000 options to buy
@ $0.19, valued at
$55.1k
|
|
| 05/19/2022 |
4
| FINKELSTEIN J J (President and CEO) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 600,000 options to buy
@ $0.19, valued at
$114k
|
|
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/02/2022 |
4
| GOLDSTEIN ALLAN L (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Gifted 130,000 shares
@ $0 |
|
| 11/17/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/15/2021 |
8-K
| Investor presentation |
| 10/19/2021 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 10/18/2021 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/08/2021 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 09/07/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/02/2021 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 08/17/2021 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 08/06/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/04/2021 |
4
| MCNAY JOSEPH C (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 290,000 options to buy
@ $0.28, valued at
$81.2k
|
|
| 08/04/2021 |
4
| GOLDSTEIN ALLAN L (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 480,000 options to buy
@ $0.28, valued at
$134.4k
|
|
| 08/04/2021 |
4
| Elsey R Don (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 290,000 options to buy
@ $0.28, valued at
$81.2k
|
|
| 08/04/2021 |
4
| Noseda Alessandro (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 240,000 options to buy
@ $0.28, valued at
$67.2k
|
|
| 08/04/2021 |
4
| Bove Mauro (Director) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 240,000 options to buy
@ $0.28, valued at
$67.2k
|
|
| 08/04/2021 |
4
| FINKELSTEIN J J (President and CEO) has filed a Form 4 on REGENERX BIOPHARMACEUTICALS INC|
Txns:
| Granted 600,000 options to buy
@ $0.28, valued at
$168k
|
|
|
|
|